StockData
Picard Medical, Inc. logo

Picard Medical, Inc. (PMI) stock

PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3076% above fair value
$6.91−0.33 (-4.56%)

Close on Nov 17, 2026Market cap $16.16MP/E –Yield –

Picard Medical r&d expenses

Research and development expenses are spending on new products and technology.

Picard Medical's R&D Expenses for the twelve months ending Sep 30, 2026 was $4.14M, up 25.7% year over year. For fiscal 2025 it was $3.05M, down 9.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.05M-9.8%
FY2024Dec 31, 2024$3.38M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$321.00K-66.2%
Q2 FY2026Jun 30, 2026$1.37M+84.9%
Q1 FY2026Mar 31, 2026$1.90M+134.5%
Q4 FY2025Dec 31, 2025$547.00K-30.7%
Q3 FY2025Sep 30, 2025$951.00K-1.0%
Q2 FY2025Jun 30, 2025$743.00K-21.0%
Q1 FY2025Mar 31, 2025$808.00K–
Q4 FY2024Dec 31, 2024$789.00K–
Q3 FY2024Sep 30, 2024$961.00K–
Q2 FY2024Jun 30, 2024$940.00K–

More Picard Medical figures

See a number that looks wrong?